| Lactate measurements in sepsis-induced tissue hypoperfusion: results from the Surviving Sepsis Campaign database B Casserly, GS Phillips, C Schorr, RP Dellinger, SR Townsend, ... Critical care medicine 43 (3), 567-573, 2015 | 649 | 2015 |
| The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients NS Ward, B Casserly, A Ayala Clinics in chest medicine 29 (4), 617-625, 2008 | 526 | 2008 |
| Induction of vascular permeability by the sphingosine-1-phosphate receptor–2 (S1P2R) and its downstream effectors ROCK and PTEN T Sanchez, A Skoura, MT Wu, B Casserly, EO Harrington, T Hla Arteriosclerosis, thrombosis, and vascular biology 27 (6), 1312-1318, 2007 | 398 | 2007 |
| Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent B Casserly, JR Klinger Drug design, development and therapy, 269-287, 2009 | 147 | 2009 |
| Reducing mortality in severe sepsis and septic shock AT Levinson, BP Casserly, MM Levy Seminars in respiratory and critical care medicine 32 (02), 195-205, 2011 | 99 | 2011 |
| How do dual long-acting bronchodilators prevent exacerbations of chronic obstructive pulmonary disease? KM Beeh, PR Burgel, FME Franssen, JL Lopez-Campos, S Loukides, ... American journal of respiratory and critical care medicine 196 (2), 139-149, 2017 | 89 | 2017 |
| Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign B Casserly, H Gerlach, GS Phillips, S Lemeshow, JC Marshall, TM Osborn, ... Intensive care medicine 38, 1946-1954, 2012 | 75 | 2012 |
| Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease AC Stone, JT Machan, J Mazer, B Casserly, JR Klinger Lung 189, 207-212, 2011 | 75 | 2011 |
| Hemodynamic monitoring in sepsis B Casserly, R Read, MM Levy Critical Care Nursing Clinics 23 (1), 149-169, 2011 | 75 | 2011 |
| Propofol infusion syndrome: an unusual cause of renal failure B Casserly, E O’Mahony, EG Timm, S Haqqie, G Eisele, R Urizar American Journal of Kidney Diseases 44 (6), e98-e101, 2004 | 73 | 2004 |
| Longitudinal trends in real-world outcomes after initiation of ivacaftor. A cohort study from the cystic fibrosis registry of Ireland L Kirwan, G Fletcher, M Harrington, P Jeleniewska, S Zhou, B Casserly, ... Annals of the American Thoracic Society 16 (2), 209-216, 2019 | 67 | 2019 |
| Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium KL Grinnell, B Casserly, EO Harrington American Journal of Physiology-Lung Cellular and Molecular Physiology 298 (3 …, 2010 | 61 | 2010 |
| Activation of endothelial BKCa channels causes pulmonary vasodilation A Vang, J Mazer, B Casserly, G Choudhary Vascular pharmacology 53 (3-4), 122-129, 2010 | 59 | 2010 |
| Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement Q Lu, EO Harrington, J Newton, B Casserly, G Radin, R Warburton, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 298 (6 …, 2010 | 56 | 2010 |
| Multimarker panels in sepsis B Casserly, R Read, MM Levy Critical care clinics 27 (2), 391-405, 2011 | 44 | 2011 |
| Using serial severity scores to predict death in ICU patients: a validation study and review of the literature EJ Gartman, BP Casserly, D Martin, NS Ward Current opinion in critical care 15 (6), 578-582, 2009 | 43 | 2009 |
| Ambrisentan for the treatment of pulmonary arterial hypertension B Casserly, JR Klinger Drug design, development and therapy, 265-280, 2009 | 43 | 2009 |
| Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials AZ Uluer, G MacGregor, P Azevedo, V Indihar, C Keating, MA Mall, ... The Lancet Respiratory Medicine 11 (6), 550-562, 2023 | 42 | 2023 |
| Association of change in depression and anxiety symptoms with functional outcomes in pulmonary rehabilitation patients PA Pirraglia, B Casserly, R Velasco, ML Borgia, L Nici Journal of psychosomatic research 71 (1), 45-49, 2011 | 41 | 2011 |
| Evaluating the use of recombinant human activated protein C in adult severe sepsis: results of the Surviving Sepsis Campaign B Casserly, H Gerlach, GS Phillips, JC Marshall, S Lemeshow, MM Levy Critical care medicine 40 (5), 1417-1426, 2012 | 38 | 2012 |
